ClinicalTrials.gg
CompletedNCT05552365RAP-iDLDUpdated Dec 4, 2024

Reducing Anxiety Problems Among Children Indicated to Have Developmental Language Disorder

An interventional study of Adapted Cognitive Behavioural and Treatment as Usual in Developmental Language Disorder and Language Impairment and Anxiety Disorders and Symptoms, sponsored by Nanyang Technological University. Completed at 1 site in Singapore. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2024-12-04.

Sponsored by Nanyang Technological University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study aims to pilot a world-first intervention, a mental health intervention augmented for children indicated with developmental language disorder (DLD). It serves as a proof-of-concept of how existing observational studies on these topics at the Centre for Research in Child Development (c.f. Tran-Sen; Gibber) can be translated into interventions. Mental health problems here are defined as anxiety type problems of social anxiety, specific phobia, separation anxiety and generalised anxiety. DLD is defined as a marked difficulty in oral language in the absence of biomedical causes (Bishop et al., 2017). This randomised pilot answers three uncertainties in preparation for a future definitive randomised control trial (RCT).

Read the detailed description

This pilot aims to answer three uncertainties for a future randomised control trial (RCT), namely (1) Is the proposed intervention's efficacy sufficient (2) Are the proposed methods of recruitment sufficient (3) Are the proposed measures of evaluation sufficient Hypotheses: (1) Piloted intervention is sufficient for definitive RCT as 90% confidence intervals contain expected improvement versus treatment-as-usual (2) Piloted recruitment methods are sufficient for definitive RCT as recruitment rate is >4/month, dropout rate\<25%. (3) Piloted measures are sufficient for definitive RCT as rates of unusable data are \<20% and reliability alpha >.70.

02

Conditions studied

  • Developmental Language Disorder and Language Impairment
  • Anxiety Disorders and Symptoms
03

In context

Language Development Disorders

121 studies on the registry are indexed under Language Development Disorders; 49 are open to participants now.

This study's enrollment of 9 is below the median of 74 across 106 interventional studies indexed under Language Development Disorders.

Browse Language Development Disorders studies →

Lead sponsor

Nanyang Technological University is the lead sponsor of 52 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Shows signs of elevated anxiety, fear or stress, as rated on anxiety measures conducted by this study
  • Enrolled in Primary 1 to 6 in a Ministry of Education Primary School
  • Signs of a language difficulty [Either one of the following]

    1. Existing clinical opinion/report of this when child >5 years old
    2. Score \<10th percentile on language measures conducted by this study

Exclusion criteria

Exclusion Criteria:

  • Conditions which exclude Developmental Language Disorder (e.g. Autism, Intellectual Disability, Hearing Impairment, other biomedical conditions).
  • Non-anxiety disorder as primary mental health disorder
  • Currently receiving treatment for anxiety disorder (e.g. pharmacotherapy or psychotherapy).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Active Intervention

    8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder.

    Behavioral: Adapted Cognitive Behavioural

  • Other
    Treatment as Usual

    Participants are re-directed to mental health support services. All participants given a mental health brochure which has contact details of mental health services for children.

    Other: Treatment as Usual

Interventions

  • BehavioralAdapted Cognitive Behavioural

    8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder. Intervention includes psychoeducative, bodily relaxation, graded exposure, cognitive restructuring and brainstorming. Adaptations include increasing the number of visual supports, use of physical objects to illustrate concepts in addition to language.

  • OtherTreatment as Usual

    Participants given a mental health brochure with contact information, where they can access services provided by mental health support service providers.

06

What researchers measure

Primary outcomes

  1. Anxiety Disorders Interview Schedule (ADIS-IV; Brown et al., 2004)

    The ADIS-IV is a semi-structured interview organised diagnostically to permit differential diagnoses of anxiety disorders. Its yields a severity rating (0 to 8) which is utilised here as the primary outcome

    Time frame: Administered at post treatment which is a maximum of 4 weeks from final session

Secondary outcomes

  1. Screen for child anxiety related emotional disorders (SCARED; Birmaher et al., 1999)

    The SCARED is a child and parent self-report instrument used to screen for childhood anxiety disorders including general anxiety disorder. The child report scores (41 items) and parent report scores (41 items) of the SCARED will be utilised here.

    Time frame: Administered at post treatment which is a maximum of 4 weeks from final session

  2. Child Anxiety Life Interference Scale (CALIS; Lyneham, et. al., 2013)

    CALIS is a 2-part scale that measures child's anxiety life interference from both the child's and parent's perspectives. The children scale is a 10-item self-reported questionnaire on questionnaire evaluating the interference to the child's life and to the parent's life. All the items are related to common daily activities. The items are rated on a 5-point Likert scale (0 = Not at all, 1 = Only a little, 2 = Sometimes, 3 = Quite a lot, 4 = A great deal), where the higher scores indicate high levels of interference. Scores from the child and parent version will be used here

    Time frame: Administered at post treatment which is a maximum of 4 weeks from final session

Other outcomes

  1. Child Outcome and Session Rating Scales (CORS; Duncan et al., 2003)

    The CORS is targeted for children aged 6 to 12 and has the same format as the Outcome Rating Scales (Duncan et al.,2003). It is written in a child-friendly language, where the child uses the happy and sad faces to understand the scale (Duncan et al., 2003).

    Time frame: At the end of each of the 8-sessions (each session is expected to run for 60 - 90 mins) for the active intervention

07

Study locations

1 site
  • Centre for Research in Child Development, OER, NIE-NTU
    Singapore, Singapore
08

References and documents

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05552365
Lead sponsor
Nanyang Technological University
Responsible party
Shaun Goh Kok Yew (Lecturer, Nanyang Technological University) — Principal investigator
First posted
Sep 23, 2022
Start date
Dec 16, 2022
Primary completion
May 14, 2024
Completion
Oct 31, 2024
Last update
Dec 4, 2024

Study contacts

Shaun KY Goh, PhD
principal investigator · NTU-NIE

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion